Buy Ozempic (Semaglutide) — Online Prescription
Semaglutide is a prescription injectable (Ozempic) or oral tablet (Rybelsus) for type 2 diabetes — not an over-the-counter weight-loss product. Covers dosing, side effects, and how it compares to Wegovy, Rybelsus, and Mounjaro.
Medically reviewed Medically reviewed by Christine Manzi, RPh — NPI 1275223448 · Last updated 2026-08-31
| Active ingredient | Semaglutide |
|---|---|
| Dosage form | Injection (Ozempic), tablet (Rybelsus) |
| Administration route | Subcutaneous injection, oral |
Class: GLP-1 Receptor Agonist [EPC]
Indications: 1 INDICATIONS AND USAGE RYBELSUS and OZEMPIC tablets are indicated: • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. • to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events. RYBELSUS and OZEMPIC tablets are glucagon-like peptide-1 (GLP-1) receptor agonists indicated: • as an adjunct to diet …
Boxed warning: WARNING: RISK OF THYROID C-CELL TUMORS • In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether RYBELSUS and OZEMPIC tablets cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions ( 5.1 ), Nonclinical Toxicology ( 13.1 )] . • RYBELSUS and OZEMPIC tablets are contraindicated in patients with a personal or family history of MTC or in patients w…
Contraindications: 4 CONTRAINDICATIONS RYBELSUS and OZEMPIC tablets are contraindicated in patients with: • A personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Warnings and Precautions ( 5.1 )] . • A prior serious hypersensitivity reaction to semaglutide or to any of the excipients in RYBELSUS or OZEMPIC tablets. Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with semaglutide tabl…
openFDA label data — Updated 2026-09-02What Ozempic is actually approved for
Ozempic (semaglutide injection) is FDA-approved as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes, and to reduce the risk of major cardiovascular events — cardiovascular death, heart attack, or stroke — in adults with type 2 diabetes at high cardiovascular risk. In January 2025, the FDA expanded approval to include reducing the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (CKD) — making it the most broadly indicated GLP-1 medication in its class. Rybelsus is the oral tablet form of semaglutide, approved for the same type 2 diabetes indications.
Ozempic itself is not FDA-approved for weight loss — that's a separate, higher-dose semaglutide product (Wegovy). Ozempic is sometimes prescribed off-label for weight loss, which is a decision between a patient and their prescriber.
How semaglutide works
Semaglutide is a GLP-1 receptor agonist — it mimics a hormone (glucagon-like peptide-1) your gut naturally releases after eating. This slows stomach emptying, prompts your pancreas to release insulin when blood sugar is high, reduces how much sugar your liver releases, and increases feelings of fullness — which is why it affects both blood sugar and appetite, even though only some semaglutide products are approved specifically for weight management.
Dosing and how the pen works
Ozempic is injected once weekly, any day, any time, with or without food — into the abdomen, thigh, or upper arm, rotating injection sites. Dosing is gradual to reduce GI side effects:
Never change your dose, skip weeks, or double up a missed dose without your prescriber's instruction. Ask our pharmacists to walk through the pen device and injection technique when you pick up a new prescription — proper technique matters for both effectiveness and comfort.
Common and serious side effects
The most commonly reported side effects are gastrointestinal — nausea, vomiting, diarrhea, abdominal pain, and constipation — and tend to be most noticeable during dose increases, often easing over time. Taking smaller meals and avoiding high-fat foods can help.
Beyond the boxed warning below, other label warnings include a risk of acute pancreatitis (seek care for severe abdominal pain that doesn't go away, especially with vomiting), gallbladder problems, kidney injury (usually related to dehydration from GI side effects), and diabetic retinopathy complications reported in a cardiovascular outcomes trial. Tell your prescriber about any new or worsening symptoms rather than waiting for a routine visit.
These aren't FDA-labeled side effects — they're patient- and media-reported phenomena tied to significant or rapid weight loss generally, not a specific drug reaction unique to semaglutide. Facial volume loss ("Ozempic face") reflects reduced facial fat with overall weight loss; temporary hair shedding (telogen effluvium) can follow major changes in weight or nutrition from any cause. Both are worth mentioning to your prescriber, who can assess pace of weight change and nutritional intake.
Boxed warning
Semaglutide's label carries a boxed warning: in rodent studies, semaglutide caused thyroid C-cell tumors, including medullary thyroid carcinoma, in a way that depended on dose and duration of exposure. Whether this risk translates to humans is unknown. Because of this, semaglutide is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and in anyone with a prior serious hypersensitivity reaction to semaglutide.
Ozempic vs. Wegovy vs. Rybelsus vs. Mounjaro/Zepbound
These get confused constantly because they're related or co-marketed — here's how they actually differ:
| Brand | Active ingredient | Form | FDA-approved use |
|---|---|---|---|
| Ozempic | Semaglutide | Weekly injection | Type 2 diabetes; cardiovascular risk reduction |
| Rybelsus | Semaglutide | Daily oral tablet | Type 2 diabetes |
| Wegovy | Semaglutide (higher max dose) | Weekly injection | Chronic weight management |
| Mounjaro | Tirzepatide | Weekly injection | Type 2 diabetes |
| Zepbound | Tirzepatide | Weekly injection | Chronic weight management |
Ozempic, Rybelsus, and Wegovy share the same active ingredient at different doses; Mounjaro and Zepbound use tirzepatide, a different molecule that acts on two gut-hormone receptors (GIP and GLP-1) instead of one. None of these are interchangeable with each other, and switching between them is a prescriber decision based on your diagnosis, response, and insurance coverage — not something to do on your own.
A note on counterfeit and compounded semaglutide
Because of high demand, the FDA has specifically warned about counterfeit and improperly compounded "semaglutide" products sold online and outside the regulated supply chain, some of which have caused serious adverse events. Semaglutide obtained outside a licensed pharmacy carries real risk — there is no way to verify what you are actually injecting. If cost is the barrier to a legitimate prescription, talk to us about manufacturer savings programs before considering an unregulated source.
Cost, insurance, and savings
Semaglutide products have experienced periods of high demand and constrained supply nationally — see the live shortage and pricing data below for the latest status we're aware of.
- Insurance coverage for Ozempic is generally more consistent when prescribed for its approved use (type 2 diabetes or diabetes with CKD) than when used off-label for weight loss, and often requires prior authorization. Check your plan's formulary or ask us to help.
- Manufacturer savings. Novo Nordisk's NovoCare savings card program has historically offered eligible commercially-insured patients a reduced monthly cost — eligibility, pricing, and terms change over time, so confirm current details directly at novocare.com or ask our pharmacists.
- Generic status. Semaglutide does not currently have an FDA-approved generic version; compounded "semaglutide" sold outside a licensed pharmacy is not a generic and is not FDA-verified (see above).
Call us at (860) 522-9289 to check current availability and what options may apply to your specific plan.
No active shortage reported — Shortage records exist for this drug historically, but none are currently marked active.
FDA openFDA — Updated 2026-09-02National Average Drug Acquisition Cost (NADAC): $33.173 per tablet (RYBELSUS 7 MG TABLET). This is the average price pharmacies pay wholesalers — not your out-of-pocket cost — published by CMS for pricing transparency.
CMS NADAC — Updated 2026-09-02Ozempic (Semaglutide) Prices in the USA
| Dosage | Brand-name avg. price |
|---|---|
| 0.25 mg / 0.5 mg pen (monthly) | $950–1,000 |
| 1 mg pen (monthly) | $950–1,000 |
| 2 mg pen (monthly) | $950–1,050 |
Frequently asked questions
What is Ozempic actually approved for?
Ozempic (semaglutide injection) is FDA-approved as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes; to reduce the risk of major cardiovascular events in adults with type 2 diabetes who are at high cardiovascular risk; and, as of a January 2025 FDA approval, to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. A different, higher-dose semaglutide product (Wegovy) is separately approved for chronic weight management — Ozempic itself is not FDA-approved as a weight-loss drug, even though it is prescribed off-label for that purpose in some cases.
Can I buy Ozempic without a prescription?
No. Semaglutide products require a prescription in the United States. Be especially cautious of compounded or gray-market "semaglutide" sold online — the FDA has issued warnings about counterfeit and improperly compounded semaglutide products that pose serious safety risks.
Why does semaglutide have a boxed warning?
In rodent studies, semaglutide caused thyroid C-cell tumors, including medullary thyroid carcinoma, in a dose- and duration-dependent way. It is not known whether this risk applies to humans, but out of caution the FDA requires this as a boxed warning, and semaglutide is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or MEN 2.
What is the Ozempic dosing schedule?
Treatment typically starts at 0.25 mg once weekly for 4 weeks — a dose meant to help your body adjust rather than to control blood sugar — then increases to 0.5 mg weekly. Your prescriber may increase the dose further (up to a maximum of 2 mg weekly) after at least 4 weeks on a given dose if additional blood sugar control is needed. Never adjust your own dose or schedule without your prescriber.
What is "Ozempic face," and is it a real side effect?
It's not an official FDA-labeled side effect or medical diagnosis — it's a popular term for the facial volume/skin changes that can accompany any significant or rapid weight loss, semaglutide-driven or otherwise, as facial fat decreases. It is a real, commonly reported cosmetic concern, just not a distinct drug reaction. Ask your prescriber if you're concerned about the pace of weight change.
Does Ozempic cause hair loss?
Hair loss is not among the most common side effects listed on Ozempic's label, but temporary hair shedding (telogen effluvium) can follow significant, rapid weight loss or major changes in nutrition or physiological stress from any cause — this has been reported anecdotally with GLP-1 medications. It's typically temporary. Mention it to your prescriber if it happens.
What's the difference between Ozempic, Wegovy, Rybelsus, and Mounjaro?
Ozempic, Wegovy, and Rybelsus all contain the same active ingredient, semaglutide, but differ in dose and FDA-approved use (see the comparison table below). Mounjaro and Zepbound contain a different active ingredient, tirzepatide, which acts on two hormone receptors (GIP and GLP-1) rather than one. They are not interchangeable, and switching between any of them should only happen under your prescriber's guidance.
Is Ozempic covered by insurance?
Coverage varies widely by plan, and is generally more consistent for its FDA-approved type 2 diabetes use than for off-label weight-loss use. Check your specific plan's formulary, and ask our pharmacists or your prescriber's office about prior authorization requirements and manufacturer savings card eligibility.
Sources
- Ozempic / Rybelsus (semaglutide) — FDA-approved prescribing information, including boxed warning — U.S. Food and Drug Administration
- Ozempic price data (average retail cash price) — GoodRx (consumer price reference)
- FDA Approves Ozempic for Reducing Risk of Kidney Disease Progression and Cardiovascular Death in Type 2 Diabetes and CKD (Jan. 28, 2025) — Novo Nordisk (FDA approval announcement)
- Wegovy (semaglutide 2.4 mg) — FDA approval and prescribing information — U.S. Food and Drug Administration
- Mounjaro / Zepbound (tirzepatide) — FDA-approved prescribing information — U.S. Food and Drug Administration
- NADAC (National Average Drug Acquisition Cost) — CMS
- FDA warning on compounded semaglutide products — U.S. FDA
- NovoCare Ozempic Savings Card (manufacturer program — eligibility and terms subject to change) — Novo Nordisk